YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

October 10, 2003

As toxicogenomics becomes more widely adopted and applied at higher throughput, it will have an impact on the continuum of drug discovery and development.

· Perform routine toxicogenomic screening using in vitro and/or in vivo assays

Lead Prioritization

Lead Optimization

Pre-Clinical Safety


P2 Clinical


· Perform routine toxicogenomic mechanism of toxicity using in vitro and/or in vivo assays

· Discover biomarkers

· Identify blood markers

Back to Microarrays That Make Drugs Safe 

For reprints and/or copyright permission, please contact Terry Manning, 781.972.1349.